BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Rapamycin effect on Wild Type and TSC deficient Mouse Embryonic Fibroblasts : Time Course

Dataset: Rapamycin effect on Wild Type and TSC deficient Mouse Embryonic Fibroblasts : Time Course

Aberrant activation of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is a common molecular event in a large variety of...

Registered by ArrayExpress Uploader
View Dataset

Aberrant activation of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is a common molecular event in a large variety of pathological settings, including genetic tumor syndromes, cancer, and obesity. However, the cell intrinsic consequences of mTORC1 activation remain poorly defined. Here, we identify global trancriptional changes in TSC1 and TSC2 null MEFs, which exhibit constitutive activation of mTORC1, compared to wild-type littermate control lines. A rapamycin time course is included to determine those changes that are dependent on mTORC1 signaling, revealing mTORC1 induced and repressed transcripts. In order to identify mTORC1-dependent transcriptional changes, we compared wild-type MEFs to both Tsc1-/- and Tsc2-/- MEFs following serum starvation, where mTORC1 signaling is off in wild-type cells and fully active in TSC-deficient cells. All cell lines were serum-starved for 24 h, and the Tsc1-/- and Tsc2-/- cells were treated with a time course of rapamycin prior to the isolation of mRNA for microarray analysis. Immortalized wild-type (Tsc2+/+ p53-/-), Tsc1-/- (p53+/+, 3T3-immortalized), and Tsc2-/- (p53-/-, derived from a littermate of the wild-type cell line) MEFs are the three cell lines used in this study and were derived in the laboratory of David J. Kwiatkowski (Brigham and Women's Hospital, Harvard Medical School, Boston, MA). Wild-type and null MEFs were grown to 70% confluence in 10 cm plates and were serum starved for 24 h in the presence of vehicle (DMSO) for 24 h or rapamycin (20 nM) for 2, 6, 12, or 24 h. All vehicle-treated samples (0 h time points) were plated in triplicate and all rapamycin time course samples were plated in duplicate. For each replicate, expression analysis was performed by hybridization to an Affymetrix Mouse 430_2 oligonucleotide microarray chip.

Species:
mouse

Samples:
25

Source:
E-GEOD-21755

PubMed:
20670887

Updated:
Dec.12, 2014

Registered:
Nov.11, 2014


Factors: (via ArrayExpress)
Sample TIME POINT GENOTYPE/VARIATION AGENT CELL LINE
GSM542346 not specified Wild Type DMSO TSC2+/+ p53-/-
GSM542346 not specified Wild Type DMSO TSC2+/+ p53-/-
GSM542346 not specified Wild Type DMSO TSC2+/+ p53-/-
GSM542349 not specified TSC2 Deficient DMSO TSC2-/- p53-/-
GSM542349 not specified TSC2 Deficient DMSO TSC2-/- p53-/-
GSM542349 not specified TSC2 Deficient DMSO TSC2-/- p53-/-
GSM542352 not specified TSC1 Deficient DMSO TSC1-/-
GSM542352 not specified TSC1 Deficient DMSO TSC1-/-
GSM542352 not specified TSC1 Deficient DMSO TSC1-/-
GSM542355 24 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542355 24 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542357 24 hours TSC1 Deficient rapamycin TSC1-/-
GSM542357 24 hours TSC1 Deficient rapamycin TSC1-/-
GSM542359 12 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542359 12 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM54236 12 hours TSC1 Deficient rapamycin TCS1-/-
GSM542362 12 hours TSC1 Deficient rapamycin TSC1-/-
GSM542363 6 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542363 6 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542365 6 hours TSC1 Deficient rapamycin TSC1-/-
GSM542365 6 hours TSC1 Deficient rapamycin TSC1-/-
GSM542367 2 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542367 2 hours TSC2 Deficient rapamycin TSC2-/- p53-/-
GSM542369 2 hours TSC1 Deficient rapamycin TSC1-/-
GSM542369 2 hours TSC1 Deficient rapamycin TSC1-/-

Tags

  • cancer
  • cell
  • line
  • obesity
  • serum

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use